Regenerative medicine (RM), particularly stem cell research, is an emerging field with significant promise for addressing complex and chronic health conditions. In Kenya, while stem cell research remains in the early stages of development, recent policy and institutional investments indicate growing governmental interest in advancing the sector. However, the legal and regulatory environments are still underdeveloped. Kenya does not yet have a dedicated legislative framework for stem cell research, and existing laws related to health, science, and innovation engage with the field only in general terms. Critical issues, such as the permissibility of embryonic stem cell research, remain unclear, leaving researchers to operate within a fragmented and ambiguous regulatory landscape. At the same time, other areas of law, such as criminal law, data protection, and intellectual property, may indirectly constrain scientific activity. In contrast, South Africa offers a more structured and explicit regulatory model that Kenya could consider and adapt to its own context. As the country moves toward regulating this evolving area of biomedical science, aligning national efforts with both regional models and international standards will be important.